Recent advances in the field of obesity treatment have brought a new drug known as ALLUVI Retatrutide. This medication is a {highlyspecific GLP-1 receptor agonist, designed to stimulate the effects of natural glucagon-like peptide-1. Retatrutide has shown impressive outcomes in clinical trials, highlighting significant decreases in body weight and